DMY Technology II Inc logo

DMYD.U - DMY Technology II Inc News Story

$18.13 -3.9  -17.7%

Sector
Technology
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6849

BUZZ-U.S. STOCKS ON THE MOVE-Chembio Diagnostics, Gogo Inc, Bio-Path Holdings, Leaf Group

Mon 5th April, 2021 2:17pm
* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh

Futures pointed to a higher opening for Wall Street's indexes on Monday, as
investors cheered strong jobs data and waited for a report on the services
sector with signals that 2021 could see the best annual economic growth in
nearly four decades.  .N 
    At 8:59 a.m. ET, Dow e-minis  1YMc1  were up 0.76% at 33,289. S&P 500
e-minis  ESc1  were up 0.69% at 4,037.5, while Nasdaq 100 e-minis  NQc1  were up
0.82% at 13,425.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** dMY Technology Group Inc II  DMYD.N , up 24.4%
 ** Leaf Group Ltd  LEAF.N , up 21.2%
 ** Invitae Corp  NVTA.N , up 10.2%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** GameStop Corp  GME.N , down 9%
 ** Tootsie Roll Industries Inc  TR.N , down 5.7%
 ** Elevate Credit Inc  ELVT.N , down 5.7%
 
 The top Nasdaq percentage gainers premarket  .PRPG.O :
 ** Chembio Diagnostics Inc  CEMI.O , up 66.5%
 ** Nano-X Imaging Ltd  NNOX.O , up 61.8%
 
 The top Nasdaq percentage losers premarket  .PRPL.O :
 ** Mountain Crest Acquisition Corp II  MCADR.O , down 19.5%
 ** Acadia Pharmaceuticals Inc  ACAD.O , down 17%
 
 
 ** Fly Leasing Ltd  FLY.N : down 0.2% premarket
 BUZZ-J.P.Morgan double-downgrades to 'underweight' after Carlyle's buy
offer urn:newsml:reuters.com:*:nL4N2LY0O5
 
 ** Supernus Pharmaceuticals Inc  SUPN.O : up 7.2% premarket
 BUZZ-Rises after FDA approves ADHD treatment  urn:newsml:reuters.com:*:nL4N2LY112
 
 ** Applied Materials Inc  AMAT.O : up 2.8% premarket
 BUZZ-Set to touch record high as CS hikes PT  urn:newsml:reuters.com:*:nL4N2LY15K
 ** Gogo Inc  GOGO.O : up 9.2% premarket
 BUZZ - William Blair upgrades to 'outperform' on attractive valuation; shares
rise  urn:newsml:reuters.com:*:nL4N2LY1B9
 ** Palantir Technologies Inc  PLTR.N : up 3.5% premarket
 BUZZ - Gains on $89.9 mln deal with U.S. nuclear weapons agency  urn:newsml:reuters.com:*:nL4N2LY1BR
 ** Acadia Pharmaceuticals  ACAD.O : down 17.0% premarket
 BUZZ - Falls as FDA declines to approve application for dementia
treatment urn:newsml:reuters.com:*:nL4N2LY175
 ** Can-Fite BioPharma  CANF.N : up 4.9% premarket
 BUZZ-Rises on positive preclinical data for cannabis compound urn:newsml:reuters.com:*:nL4N2LY1AX
 ** Cidara Therapeutics  CDTX.O : up 6.7% premarket
 BUZZ - Up on JNJ collab for influenza treatment  urn:newsml:reuters.com:*:nL4N2LY1AZ
 ** JetBlue Airways Corp  JBLU.O : up 3.3% premarket
 BUZZ - Takes off as Raymond James upgrades on improving trends urn:newsml:reuters.com:*:nL4N2LY1BJ
 
 ** GameStop Corp  GME.N : down 9.0% premarket
 BUZZ-Falls on planned 3.5 mln share at-the-market equity offering  urn:newsml:reuters.com:*:nL4N2LY155 
 
 
 ** Bandwidth Inc  BAND.O : up 2.0% premarket 
 BUZZ-Morgan Stanley upgrades to 'equal-weight', shares rise  urn:newsml:reuters.com:*:nL4N2LY153
 
 ** Cidara Therapeutics Inc  CDTX.O : up 6.7% premarket
 BUZZ-Up on JNJ collab for influenza treatment  urn:newsml:reuters.com:*:nL4N2LY1AZ
 
 ** Chembio Diagnostics Inc  CEMI.O : up 66.5% premarket
 BUZZ-Jumps on U.S. launch of tool to differentiate COVID-19 and flu
 urn:newsml:reuters.com:*:nL4N2LY1E8
 
 ** Corning Inc  GLW.N : up 2.3% premarket
 BUZZ-Rises after new investment deal with Samsung Display  urn:newsml:reuters.com:*:nL4N2LY1F3
  
 ** Bio-Path Holdings Inc  BPTH.O : up 14.0% premarket
 BUZZ-Jumps on completing safety check of cancer treatment trial  urn:newsml:reuters.com:*:nL4N2LY1GM
 
 
 
 

 (Compiled by Amruta Khandekar and Mrinalika Roy in Bengaluru)
 ((Amruta.Khandekar@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.